Granulomatosis with Polyangiitis
What is Granulomatosis with Polyangiitis?
Granulomatosis with Polyangiitis is a rare condition that causes inflammation in the blood vessels throughout your body. This inflammation can restrict blood flow to important organs and tissues. The condition was previously called Wegener's granulomatosis.
The disease creates clusters of inflamed cells called granulomas in your blood vessel walls. These granulomas most commonly affect the respiratory system, including the sinuses, nose, windpipe, and lungs. The kidneys are also frequently involved. Without treatment, this condition can cause serious damage to affected organs.
This is an autoimmune disease, which means your immune system mistakenly attacks your own blood vessels. While rare, affecting about 3 in 100,000 people per year, it requires prompt medical attention. Early diagnosis and treatment can help prevent permanent organ damage and improve long-term outcomes.
Symptoms
- Persistent runny nose that does not improve with typical treatments
- Nosebleeds and crusting around the nostrils
- Sinus pain and repeated sinus infections
- Coughing, sometimes with bloody mucus
- Shortness of breath or wheezing
- Fever and night sweats
- Fatigue and general feeling of being unwell
- Joint pain and swelling
- Weight loss without trying
- Skin sores or rashes
- Eye redness, pain, or vision changes
- Ear infections and hearing problems
Some people have mild symptoms at first that gradually worsen over weeks or months. Early kidney involvement may not cause noticeable symptoms until significant damage has occurred. This is why specialized blood tests and medical monitoring are essential for diagnosis.
Concerned about Granulomatosis with Polyangiitis? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Granulomatosis with Polyangiitis happens when your immune system creates antibodies that attack proteins in certain white blood cells. These antibodies, called antineutrophil cytoplasmic antibodies or ANCA, cause inflammation in blood vessel walls. The exact reason why the immune system begins this attack is not fully understood. Researchers believe a combination of genetic factors and environmental triggers may play a role.
The condition can affect anyone but is most commonly diagnosed in adults between ages 40 and 65. Men and women are affected equally. White individuals have slightly higher rates than other ethnic groups. Unlike some autoimmune diseases, this condition is not directly inherited, though some families may have a slightly higher risk. Certain infections may trigger the disease in people who are already genetically susceptible, but no specific cause has been proven.
How it's diagnosed
Doctors diagnose Granulomatosis with Polyangiitis through a combination of symptoms, blood tests, imaging studies, and tissue biopsies. Blood tests look for specific antibodies called ANCA, particularly Proteinase-3 antibodies which are found in about 80 to 90 percent of people with this condition. Some people test positive for Myeloperoxidase antibodies instead. These specialized antibody tests help confirm the diagnosis.
Additional tests include urine analysis to check for kidney involvement, chest X-rays or CT scans to look at the lungs, and sometimes a biopsy of affected tissue. A biopsy shows the characteristic granulomas and inflammation that define this disease. Early diagnosis is critical to prevent organ damage. If you have concerning symptoms, talk to a doctor about testing. Our care team can help connect you with specialists who manage this condition.
Treatment options
- Immunosuppressive medications to reduce immune system activity and control inflammation
- Corticosteroids like prednisone to quickly reduce inflammation during flares
- Rituximab, a biologic medication that targets specific immune cells
- Cyclophosphamide for severe cases affecting major organs
- Methotrexate or azathioprine for maintenance therapy after initial treatment
- Regular monitoring with blood tests and imaging to track disease activity
- Treatment of infections promptly, as immunosuppressive drugs increase infection risk
- Supportive care for affected organs, such as dialysis for severe kidney damage
- Physical therapy to maintain strength and mobility if joints are affected
- Adequate rest and stress management to support overall health
Frequently asked questions
Early signs often involve the upper respiratory tract, including persistent runny nose, nosebleeds, sinus pain, and repeated sinus infections that do not respond to typical treatments. Some people experience general symptoms like fatigue, fever, and joint pain. These symptoms may seem minor at first but gradually worsen over time, making early medical evaluation important.
This condition specifically creates granulomas, which are clusters of inflamed cells, in the blood vessel walls. It has a strong tendency to affect the respiratory tract and kidneys together. The presence of Proteinase-3 antibodies in the blood is a distinctive feature found in most cases. Other forms of vasculitis may affect different organs or have different antibody patterns.
There is no cure currently, but the disease can be controlled with proper treatment. Many people achieve remission, meaning the disease becomes inactive and symptoms disappear. Remission may last for years with maintenance medication. Some people experience flares where symptoms return, requiring adjustments to treatment.
The main diagnostic blood test looks for antineutrophil cytoplasmic antibodies, specifically Proteinase-3 antibodies which are positive in most cases. Some people test positive for Myeloperoxidase antibodies instead. Doctors also check markers of inflammation like erythrocyte sedimentation rate and C-reactive protein. Kidney function tests and complete blood counts help assess organ involvement.
Without treatment, this condition can be life-threatening because it may damage vital organs like the lungs and kidneys. The inflammation can lead to kidney failure or severe lung bleeding. With early diagnosis and appropriate treatment, most people can live normal or near-normal lives. Regular medical monitoring helps catch and treat flares before they cause serious damage.
During active disease, you may need blood tests and medical visits every few weeks to monitor treatment response. Once in remission, monitoring typically happens every 3 to 6 months. Your doctor will check antibody levels, kidney function, and inflammation markers. Regular urine tests help catch kidney problems early before symptoms appear.
Flares can happen even with treatment, though the exact triggers are not always clear. Infections may trigger increased immune activity and disease flares. Stress, medication changes, or reducing immunosuppressive drugs too quickly can also lead to flares. Some flares occur without any identifiable cause, which is why regular monitoring is essential.
While lifestyle changes cannot cure or control the disease alone, they support overall health and treatment effectiveness. Getting adequate rest helps your body manage inflammation. Avoiding infections by practicing good hygiene and staying current on vaccines is important. Eating a balanced diet and staying physically active as your symptoms allow can improve quality of life.
Immunosuppressive medications reduce your immune system's ability to fight infections, making you more susceptible to illness. Corticosteroids can cause weight gain, mood changes, high blood sugar, and weakened bones with long-term use. Other medications may cause nausea, liver problems, or changes in blood cell counts. Your doctor will monitor you closely and adjust medications to balance disease control with side effects.
Women with this condition can have successful pregnancies, but careful planning and monitoring are essential. Some medications used to treat the disease can harm a developing baby and must be changed before conception. Active disease during pregnancy increases risks for both mother and baby. Working closely with your rheumatologist and obstetrician before and during pregnancy helps ensure the best outcomes.